NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 207 filers reported holding NEKTAR THERAPEUTICS in Q1 2017. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,097 | +965.0% | 1,841,078 | +931.5% | 0.09% | +840.0% |
| Q2 2023 | $103 | -18.9% | 178,489 | -1.0% | 0.01% | -23.1% |
| Q1 2023 | $127 | -91.3% | 180,363 | -72.0% | 0.01% | -92.8% |
| Q4 2022 | $1,458 | -99.2% | 645,035 | +988.0% | 0.18% | +624.0% |
| Q3 2022 | $190,000 | +23.4% | 59,287 | +46.7% | 0.02% | +8.7% |
| Q2 2022 | $154,000 | +8.5% | 40,426 | +284.0% | 0.02% | +27.8% |
| Q4 2021 | $142,000 | -65.0% | 10,527 | -53.4% | 0.02% | -56.1% |
| Q3 2021 | $406,000 | -73.0% | 22,583 | -74.2% | 0.04% | -75.7% |
| Q2 2021 | $1,504,000 | +203.2% | 87,659 | +193.1% | 0.17% | +103.6% |
| Q3 2020 | $496,000 | -48.3% | 29,909 | +90.1% | 0.08% | +56.6% |
| Q3 2018 | $959,000 | +18.4% | 15,737 | -5.1% | 0.05% | +32.5% |
| Q2 2018 | $810,000 | -4.7% | 16,586 | +16.5% | 0.04% | -23.1% |
| Q4 2017 | $850,000 | -41.5% | 14,236 | -76.5% | 0.05% | -47.5% |
| Q3 2017 | $1,454,000 | +372.1% | 60,598 | +141.4% | 0.10% | +450.0% |
| Q4 2016 | $308,000 | -16.1% | 25,105 | -6.0% | 0.02% | -21.7% |
| Q1 2016 | $367,000 | -38.5% | 26,713 | -24.6% | 0.02% | -20.7% |
| Q4 2015 | $597,000 | +20.4% | 35,416 | -21.8% | 0.03% | +20.8% |
| Q3 2015 | $496,000 | -66.3% | 45,292 | -61.5% | 0.02% | -57.1% |
| Q2 2015 | $1,471,000 | +7.7% | 117,578 | -5.3% | 0.06% | +3.7% |
| Q1 2015 | $1,366,000 | +120.7% | 124,206 | +211.0% | 0.05% | +25.6% |
| Q4 2014 | $619,000 | -16.5% | 39,935 | -34.9% | 0.04% | +10.3% |
| Q3 2014 | $741,000 | +152.9% | 61,361 | +168.9% | 0.04% | +200.0% |
| Q2 2014 | $293,000 | – | 22,816 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |